ALK positivity, defined according to Ventana CDx guidelines, was identified in 16 tumors (2.0 %), including 12 adenocarcinomas, two non-small cell carcinoma NOS, and two squamous cell carcinomas. Here, ALK is linked to non-small cell lung carcinoma.